Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
1.730
+0.010 (0.58%)
At close: Nov 18, 2026, 4:00 PM EST
1.725
-0.005 (-0.29%)
After-hours: Nov 18, 2026, 5:22 PM EST
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $36.39 million as of November 18, 2026. It is the 32,076th most valuable company in the world and the 4,743rd biggest in the United States. Its market cap has decreased by 14.17% in one year.
Market Cap
36.39M
Enterprise Value
15.08M
1-Year Change
-14.17%
Global Rank
Country Rank
#4,743 United States
Category
ChartMarket Cap Chart
Since January 9, 2015, Grace Therapeutics's market cap has decreased from $6.81B to $36.39M, a decrease of -99.47%. That is a compound annual growth rate of -35.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 36.39M | -25.58% |
| Dec 31, 2025 | 48.90M | 29.02% |
| Dec 31, 2024 | 37.90M | 39.34% |
| Dec 29, 2023 | 27.20M | 21.43% |
| Dec 30, 2022 | 22.40M | -59.86% |
| Dec 31, 2021 | 55.80M | 77.14% |
| Dec 31, 2020 | 31.50M | -84.91% |
| Dec 31, 2019 | 208.70M | 584.26% |
| Dec 31, 2018 | 30.50M | 119.42% |
| Dec 29, 2017 | 13.90M | 3.73% |
| Dec 30, 2016 | 13.40M | -99.80% |
| Jan 9, 2015 | 6.81B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apollomics | 37.30M |
| Hyperion DeFi | 36.98M |
| Caribou Biosciences | 36.81M |
| Instil Bio | 36.62M |
| Veru Inc. | 36.49M |
| Connect Biopharma Holdings | 36.45M |
| Biomea Fusion | 35.37M |
| Serina Therapeutics | 34.67M |